OVESTIN Trademark

Trademark Overview

On Friday, September 4, 2020, a trademark application was filed for OVESTIN with the United States Patent and Trademark Office. The USPTO has given the OVESTIN trademark a serial number of 90159381. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by Aspen Global Incorporated. The OVESTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hormone replacement therapy
ovestin

General Information

Serial Number90159381
Word MarkOVESTIN
Filing DateFriday, September 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for hormone replacement therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAspen Global Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Bay BRNCO8078
MU
Party NameAspen Global Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Bay BRNCO8078
MU

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2020NEW APPLICATION ENTERED
Tuesday, October 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Friday, January 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 27, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 27, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 7, 2022SOU EXTENSION 2 FILED
Monday, February 7, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 21, 2023SOU EXTENSION 4 GRANTED
Wednesday, October 26, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 26, 2022SOU EXTENSION 3 FILED
Wednesday, October 26, 2022SOU EXTENSION 3 GRANTED
Friday, April 21, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 21, 2023SOU EXTENSION 4 FILED
Tuesday, April 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 25, 2023SOU EXTENSION 5 FILED
Tuesday, October 31, 2023SOU EXTENSION 5 GRANTED
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

ovestin therapy replacement hormone preparations pharmaceutical